Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From Structural Studies to HCV Vaccine Design.

Viruses - 4 May 2021

Yechezkel Itai, Law Mansun, Tzarum Netanel

Abstract excerpt

Hepatitis C virus (HCV) is a serious and growing public health problem despite recent developments of antiviral therapeutics. To achieve global elimination of HCV, an effective cross-genotype vaccine is needed. The failure of previous vaccination trials to elicit an effective cross-reactive immune response demands better vaccine antigens to induce a potent cross-neutralizing response to improve vaccine efficacy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Cross Reactions
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C Antibodies

Share to Hepatitis C Antigens

Share to Viral Hepatitis Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 34064532
DOI: 10.3390/v13050833
PMCID: PMC8147963

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From Structural Studies to HCV Vaccine Design.PMID 34064532Read ↗

Viral evasion and challenges of hepatitis C virus vaccine development.Semantic proximity Read ↗

Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralizationSemantic proximity Read ↗

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design.Semantic proximity Read ↗

Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine DevelopmentSemantic proximity Read ↗

Can Broadly Neutralizing Monoclonal Antibodies Lead to a Hepatitis C Virus Vaccine?Semantic proximity Read ↗

Rational design of hepatitis C virus E2 core nanoparticle vaccinesSemantic proximity Read ↗

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization ResistanceSemantic proximity Read ↗

Structural perspectives on HCV humoral immune evasion mechanisms.Semantic proximity Read ↗

Distinct mechanisms of antibody-mediated HCV neutralization revealed by nanobody-guided epitope mappingSemantic proximity Read ↗

Genetic and structural insights into broad neutralization of hepatitis C virus by human V H 1-69 antibodiesSemantic proximity Read ↗

Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance.Semantic proximity Read ↗

Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.